Nanomedicine specialist named chair in medical discovery at Cedars-Sinai
Click Here to Manage Email Alerts
Lali Medina-Kauwe, PhD, has been named the inaugural Carol Moss Foundation chair in medical discovery at Cedars-Sinai.
Medina-Kauwe is associate director for basic research in Cedars-Sinai Cancer. She also is co-director of the PhD program in biomedical and translational research at Cedars-Sinai Graduate School, as well as professor in the department of biomedical sciences.
“I'm honored to hold this new position," Medina-Kauwe said in a press release. "I would like to thank the Carol Moss Foundation for recognizing that it takes creativity, out-of-the-box thinking and innovation for the multidisciplinary and transdisciplinary work that has the potential for translating into the clinic.”
Medina-Kauwe — who joined Cedars-Sinai in 2003 — is recognized for her expertise in nanomedicine. She has created nanoparticle therapies designed to stop cancer growth.
Her current research includes efforts to develop technology to delivery therapies to triple-negative breast cancer cells that spread to the brain.
“Dr. Medina-Kauwe’s creative work on the use of nanoparticles to target therapies directly to malignant cells has propelled her terrific career accomplishments,” Shlomo Melmed, MB, ChB, dean of the medical faculty at Cedars-Sinai, as well as Helene A. and Philip E. Hixon distinguished chair in investigative medicine, said in the release. “We are delighted to recognize her pioneering work and look forward to many more years of her innovative discovery here at Cedars-Sinai.”
Collapse
Press Release
Read more about
Click Here to Manage Email Alerts